Saroja Pharma Industries India Limited (NSE:SAROJA)
32.50
0.00 (0.00%)
Jun 3, 2026, 1:27 PM IST
NSE:SAROJA Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 3.39 | 3.32 | 3.22 | 3.64 | 2.65 |
Cash & Short-Term Investments | 3.39 | 3.32 | 3.22 | 3.64 | 2.65 |
Cash Growth | 1.99% | 3.20% | -11.62% | 37.60% | 6353.66% |
Accounts Receivable | 173.03 | 265.78 | 162.4 | 111.08 | 139.8 |
Other Receivables | - | 1.38 | 5.74 | 5.52 | 0.76 |
Receivables | 173.31 | 267.17 | 168.14 | 116.59 | 140.56 |
Inventory | 8.6 | 0.99 | 3.98 | 38.66 | 4.67 |
Prepaid Expenses | - | 0.21 | 0.19 | 0.35 | 0.48 |
Other Current Assets | 0.3 | 0.48 | 0.45 | 2.25 | 2.57 |
Total Current Assets | 185.59 | 272.16 | 175.98 | 161.49 | 150.92 |
Property, Plant & Equipment | 225.17 | 111.19 | 86.39 | 40.03 | 3.42 |
Long-Term Investments | 5.41 | 3.41 | 1.99 | 1.42 | 0.39 |
Other Intangible Assets | - | - | - | 0.01 | 0.03 |
Other Long-Term Assets | - | 8.76 | 1.27 | 10.45 | 0.37 |
Total Assets | 417.47 | 395.53 | 265.62 | 213.4 | 155.12 |
Accounts Payable | 84.65 | 136.49 | 56.09 | 58.63 | 53.05 |
Accrued Expenses | - | 0.1 | 0.23 | 0.17 | 0.24 |
Short-Term Debt | 70.54 | 80.75 | 31.14 | 73.77 | 44.42 |
Current Income Taxes Payable | - | 0.81 | 0.04 | 1.72 | - |
Other Current Liabilities | 15.73 | 6.74 | 5.42 | - | 0.14 |
Total Current Liabilities | 170.92 | 224.9 | 92.92 | 134.29 | 97.85 |
Long-Term Debt | 73.61 | 13.81 | 26.21 | 28.12 | 16.97 |
Long-Term Deferred Tax Liabilities | 0.04 | 0.07 | 0.09 | 0.13 | 0.03 |
Other Long-Term Liabilities | - | 0 | - | - | - |
Total Liabilities | 244.57 | 238.77 | 119.21 | 162.53 | 114.86 |
Common Stock | 40.21 | 40.21 | 40.21 | 29.36 | 2.26 |
Additional Paid-In Capital | - | 75.92 | 75.92 | - | 17.34 |
Retained Earnings | 132.7 | 40.63 | 30.29 | 21.51 | 20.66 |
Shareholders' Equity | 172.9 | 156.76 | 146.42 | 50.87 | 40.26 |
Total Liabilities & Equity | 417.47 | 395.53 | 265.62 | 213.4 | 155.12 |
Total Debt | 144.15 | 94.56 | 57.35 | 101.89 | 61.39 |
Net Cash (Debt) | -140.76 | -91.24 | -54.13 | -98.25 | -58.74 |
Net Cash Per Share | -34.97 | -22.69 | -15.33 | -33.44 | -20.43 |
Filing Date Shares Outstanding | 4.04 | 4.02 | 4.02 | 2.94 | 2.94 |
Total Common Shares Outstanding | 4.04 | 4.02 | 4.02 | 2.94 | 2.94 |
Working Capital | 14.67 | 47.27 | 83.06 | 27.2 | 53.06 |
Book Value Per Share | 42.83 | 38.99 | 36.42 | 17.33 | 13.71 |
Tangible Book Value | 172.9 | 156.76 | 146.42 | 50.85 | 40.23 |
Tangible Book Value Per Share | 42.83 | 38.99 | 36.42 | 17.32 | 13.71 |
Land | - | 18.97 | 18.97 | 18.97 | - |
Machinery | - | 9.5 | 8.42 | 4.5 | 4.09 |
Construction In Progress | - | 86.13 | 61.27 | 17.89 | - |